5-ETHYL-N-(2-FLUORO-4-(TRIFLUOROMETHYL)PHENYL)-6-((5R)-1-((5-HYDROXY-6-METHYL-4-PYRIMIDINYL)CARBONYL)-1,7-DIAZASPIRO(4.4)NON-7-YL)-2-(4-MORPHOLINYL)-7-OXO-(1,2,4)TRIAZOLO(1,5-A)PYRIMIDINE-4(7H)-ACETAMIDE
UNII G4GZJ6T7RF
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-ethyl-n-(2-fluoro-4-(trifluoromethyl)phenyl)-6-((5r)-1-((5-hydroxy-6-methyl-4-pyrimidinyl)carbonyl)-1,7-diazaspiro(4.4)non-7-yl)-2-(4-morpholinyl)-7-oxo-(1,2,4)triazolo(1,5-a)pyrimidine-4(7h)-acetamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) G4GZJ6T7RF.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3095286-53-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C33H36F4N10O5 BNHUFESXXQXFIQ-JGCGQSQUSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-ethyl-n-(2-fluoro-4-(trifluoromethyl)phenyl)-6-((5r)-1-((5-hydroxy-6-methyl-4-pyrimidinyl)carbonyl)-1,7-diazaspiro(4.4)non-7-yl)-2-(4-morpholinyl)-7-oxo-(1,2,4)triazolo(1,5-a)pyrimidine-4(7h)-acetamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.